Condition: Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria · Sponsor: Assistance Publique - Hôpitaux de Paris
Main objective of this multisite randomised study aims to demonstrate in patients with active cancer and symptomatic or incidental PE without HESTIA criteria, that home treatment is non-inferior to hospitalisation as regards the 14-day rate of the composite primary endpoint. Primary endpoint corresponds to the rate of the composite of centrally adjudicated recurrent incidental or symptomatic VTE (i.e. non fatal or fatal PE, proximal and/or distal deep venous thrombosis (DVT) of lower limb or upper limb or catheter-related thrombosis), major or clinically relevant non-major bleeding and all-cause death within 14 days following randomisation. This composite endpoint represents the net clinical benefit of outpatient care. Included patients will be randomised into two groups and stratified according to symptomatic or incidental PE, site of cancer, localised or metastatic cancer and centre. Patients randomised to the home-treatment group will be discharged home within 24hrs after randomisation. Patients will be contacted by the local thrombosis team by phone within 7 days following inclusion. Patients randomised to the hospitalisation group will be admitted in the hospital during at least 48hrs after randomisation. After this time, physicians in charge of the patients will be free to discharge the patients.
This description comes directly from the study's public registry record.
Cleo BOURGEOIS · +33156095638 · cleo.bourgeois@aphp.fr
Always discuss trial participation with your own doctor first.
| C05 - Médecine Interne - Hôpital Louis Mourier - APHP | Colombes, France, France | Recruiting |
| C04 - Oncologie Médicale - Centre Georges-François Leclerc - CLCC | Dijon, France, France | Not Yet Recruiting |
| C06 - Pneumologie - Hôpital Cochin - APHP | Paris, France, France | Not Yet Recruiting |
| C01 - Pneumologie et Soins Intensifs - HEGP | Paris, France, France | Recruiting |
| C03 - Médecine interne et médecine vasculaire - Hospices Civils de Lyon | Pierre-Bénite, France, France | Recruiting |
| C02 - Département interdisciplinaire d'organisation des parcours patients - Institut gustave Roussy | Villejuif, France, France | Recruiting |
| C12 - Médecine Vasculaire - CHU Amiens Picardie | Amiens, France | Recruiting |
| C10 - Département médecine urgence - CHU Angers | Angers, France | Recruiting |
| C08 - Département de Médecine interne et pneumologie - CHU la Cavale Blanche | Brest, France | Recruiting |
| C11 - Pneumologie - CH René Dubos | Cergy-Pontoise, France | Recruiting |
| C16 - Département Urgences - CHU Clermont Ferrand | Clermont-Ferrand, France | Recruiting |
| C13 - Médecine Vasculaire - CHU Dijon | Dijon, France | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07315347